ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
125 hedge funds and large institutions have $480M invested in Achillion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 129 → 125 (-4)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Holders
125
Holding in Top 10
4
Calls
$1.89M
Puts
$1.16M
Top Buyers
| 1 | +$28.1M | |
| 2 | +$9.59M | |
| 3 | +$6.32M | |
| 4 |
AC
Armistice Capital
New York
|
+$4.58M |
| 5 |
AG
Artal Group
Luxembourg
|
+$4.49M |
Top Sellers
| 1 | -$16M | |
| 2 | -$11.7M | |
| 3 | -$4.97M | |
| 4 |
Goldman Sachs
New York
|
-$4.07M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.41M |